News

PMCPA News

Press releases appear below, filter by date.

Novartis, Pfizer, Otsuka and Novo Nordisk named in advertisements for breaches of the ABPI Code
Press release: 05 July 2024
PMCPA Annual Report 2022 and 2023
Press release: 09 September 2024
New Appointments at the PMCPA
Press release: 09 September 2024
2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA

2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA

Press release: 23 September 2024
Documents outlining the changes to the ABPI Code (Updated)
Press release: 01 October 2024
Webinars on changes in 2024 Code and an interactive e-learning module have been published

Three ‘On demand’ webinars explaining the changes in the 2024 ABPI Code are now available free of charge on the new dedicated learning portal for the Prescription Medicines Code of Practice Authority (PMCPA). 

An interactive e-learning module targeted at individuals requiring an overview of the ABPI Code has now also been launched on the learning portal.

 

Press release: 10 October 2024
2024 Code Clause 12 Q&As - updated

The 2024 Code Clause 12 Q and As - updated to include new Q and on 14 October 2024

Press release: 14 October 2024
Novo Nordisk, Moderna, Otsuka, AstraZeneca and Daiichi Sankyo named in advertisements for breaches of the ABPI Code

Clause 2 Adverts - press release 

Press release: 24 October 2024
The PMCPA website has been updated

The PMCPA website has been updated - to view this you may need to clear the cache on your browser.

Press release: 06 November 2024
Windsor Framework

PMCPA guidance for promotional material published

Press release: 07 November 2024
2024 Code Clause 10.4 Q&As

Now published

Press release: 21 November 2024
PMCPA PRESS RELEASE 17 February 2025

Cases ruled in breach of Clause 2 

Press release: 17 February 2025
About 154 result(s)